RU2615443C2 - Комбинированная вакцина pcv/mycoplasma hyopneumoniae - Google Patents

Комбинированная вакцина pcv/mycoplasma hyopneumoniae Download PDF

Info

Publication number
RU2615443C2
RU2615443C2 RU2014140106A RU2014140106A RU2615443C2 RU 2615443 C2 RU2615443 C2 RU 2615443C2 RU 2014140106 A RU2014140106 A RU 2014140106A RU 2014140106 A RU2014140106 A RU 2014140106A RU 2615443 C2 RU2615443 C2 RU 2615443C2
Authority
RU
Russia
Prior art keywords
hyo
pcv2
composition
antigen
protein
Prior art date
Application number
RU2014140106A
Other languages
English (en)
Russian (ru)
Other versions
RU2014140106A (ru
Inventor
Грегори П. НИТЦЕЛЬ
Джефри Е. ГЭЛВИН
Джон Кейт ГАРРЕТ
Джеймс Р.II КЬЮЛОВИК
Трейси Л. РИКЕР
Меган Мари СМАТЦЕР
Original Assignee
Зоэтис Сервисиз Ллс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48182999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2615443(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Зоэтис Сервисиз Ллс filed Critical Зоэтис Сервисиз Ллс
Publication of RU2014140106A publication Critical patent/RU2014140106A/ru
Application granted granted Critical
Publication of RU2615443C2 publication Critical patent/RU2615443C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2014140106A 2012-04-04 2013-04-03 Комбинированная вакцина pcv/mycoplasma hyopneumoniae RU2615443C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261620175P 2012-04-04 2012-04-04
US61/620,175 2012-04-04
PCT/US2013/035088 WO2013152083A2 (en) 2012-04-04 2013-04-03 Pcv/mycoplasma hyopneumoniae combination vaccine

Publications (2)

Publication Number Publication Date
RU2014140106A RU2014140106A (ru) 2016-05-27
RU2615443C2 true RU2615443C2 (ru) 2017-04-04

Family

ID=48182999

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014140106A RU2615443C2 (ru) 2012-04-04 2013-04-03 Комбинированная вакцина pcv/mycoplasma hyopneumoniae

Country Status (32)

Country Link
US (5) US9125885B2 (cg-RX-API-DMAC10.html)
EP (2) EP2833910B1 (cg-RX-API-DMAC10.html)
JP (1) JP6271503B2 (cg-RX-API-DMAC10.html)
KR (3) KR20180049221A (cg-RX-API-DMAC10.html)
CN (1) CN104334186B (cg-RX-API-DMAC10.html)
AR (1) AR090615A1 (cg-RX-API-DMAC10.html)
AU (1) AU2013243537B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014024785B1 (cg-RX-API-DMAC10.html)
CA (1) CA2869594C (cg-RX-API-DMAC10.html)
CL (1) CL2014002675A1 (cg-RX-API-DMAC10.html)
CO (1) CO7160025A2 (cg-RX-API-DMAC10.html)
CR (1) CR20140437A (cg-RX-API-DMAC10.html)
CY (1) CY1121998T1 (cg-RX-API-DMAC10.html)
DK (1) DK2833910T3 (cg-RX-API-DMAC10.html)
ES (1) ES2721925T3 (cg-RX-API-DMAC10.html)
HR (2) HRP20140954A2 (cg-RX-API-DMAC10.html)
HU (1) HUE043322T2 (cg-RX-API-DMAC10.html)
LT (1) LT2833910T (cg-RX-API-DMAC10.html)
MX (2) MX336503B (cg-RX-API-DMAC10.html)
MY (2) MY174622A (cg-RX-API-DMAC10.html)
NI (1) NI201400119A (cg-RX-API-DMAC10.html)
PH (1) PH12014502251B1 (cg-RX-API-DMAC10.html)
PL (1) PL2833910T3 (cg-RX-API-DMAC10.html)
PT (1) PT2833910T (cg-RX-API-DMAC10.html)
RS (1) RS58481B1 (cg-RX-API-DMAC10.html)
RU (1) RU2615443C2 (cg-RX-API-DMAC10.html)
SI (1) SI2833910T1 (cg-RX-API-DMAC10.html)
TR (1) TR201904603T4 (cg-RX-API-DMAC10.html)
TW (1) TWI602574B (cg-RX-API-DMAC10.html)
UA (1) UA114503C2 (cg-RX-API-DMAC10.html)
WO (1) WO2013152083A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201406974B (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
AU2013370982C9 (en) * 2012-12-28 2019-01-24 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
EP2994162B1 (en) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccine for pcv2 and mycoplasma
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
PL3076996T3 (pl) * 2013-12-03 2020-05-18 Intervet International B.V. Szczepionka przeciwko cirkowirusowi świń typu 2
WO2015082457A1 (en) * 2013-12-03 2015-06-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
US9713639B2 (en) * 2014-05-19 2017-07-25 Merial, Inc. Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
EP3229832A1 (en) * 2014-12-11 2017-10-18 Intervet International B.V. Process for ready-to-use pcv2/m.hyo combination vaccine
AU2016380864B2 (en) 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
BR112018069100A2 (pt) * 2016-03-23 2019-01-29 Intervet International B.V. uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae
BR112018069219A2 (pt) 2016-03-23 2019-01-22 Intervet Int Bv uma vacina para aplicação intradérmica contra infecção pelo vírus pcv2 e prrs
CA3045563C (en) 2016-12-23 2022-05-03 Intervet International B.V. Combination vaccine for swine
CN106668855B (zh) * 2017-02-03 2020-11-24 四川省华派生物制药有限公司 猪肺炎支原体灭活疫苗与猪瘟活疫苗组合疫苗及其制备方法
CA3058281A1 (en) * 2017-04-13 2018-10-18 Intervet International B.V. Vaccines containing swine pathogens for associated non-mixed use
CN109010818B (zh) 2017-06-09 2021-11-09 普莱柯生物工程股份有限公司 一种预防和/或治疗猪圆环病毒感染的二联疫苗组合物及其制备方法和应用
CN109125719B (zh) * 2017-06-19 2022-06-14 普莱柯生物工程股份有限公司 一种含猪圆环病毒3型、猪圆环病毒2型抗原的免疫原性组合物及其应用
CN109207502B (zh) * 2018-10-10 2021-08-10 浙江洪晟生物科技股份有限公司 猪支原体肺炎和猪圆环病毒2型重组蛋白及制备二联疫苗
CN109234418B (zh) * 2018-11-20 2021-08-13 湖南中净生物科技有限公司 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法
US20230241198A1 (en) * 2020-07-24 2023-08-03 Boehringer Ingelheim Animal Health USA Inc. Combination porcine vaccine
CN112294953A (zh) * 2020-12-31 2021-02-02 北京科牧丰生物制药有限公司 一种pcv2型杆状病毒载体、猪肺炎支原体、副猪嗜血杆菌三联灭活疫苗及制备方法
WO2022186661A1 (ko) * 2021-03-04 2022-09-09 주식회사 이노백 돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물
KR102646305B1 (ko) * 2021-03-04 2024-03-13 주식회사 이노백 돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물
CN115887636B (zh) * 2022-01-18 2026-07-03 武汉科前生物股份有限公司 猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法
CN118477172A (zh) * 2024-01-09 2024-08-13 浙江鼎持生物制品有限公司 一种猪三联灭活疫苗及其制备方法
CN120173827A (zh) * 2025-05-20 2025-06-20 首都儿科研究所 一种人源肺炎支原体培养用培养基及其制备方法和应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028472A1 (en) * 1995-03-16 1996-09-19 The University Of Melbourne Antigen composition against mycoplasma
WO2004058142A2 (en) * 2002-05-17 2004-07-15 Wyeth Improved combine vaccine against mycoplasma hyopneumoniae and porcine viruses
WO2009126356A2 (en) * 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
RU2008130927A (ru) * 2005-12-29 2010-02-10 Берингер Ингельхайм Ветмедика, Инк. (Us) Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций
WO2011141443A1 (en) * 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
RU2010117614A (ru) * 2007-11-06 2011-12-20 ВАЙЕТ ЭлЭлСи (US) Авирулентная адъювантная живая вакцина против mycoplasma hyopneumoniae

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB228811A (en) 1924-11-04 1925-02-12 Congoleum Company Inc Improvements in stands or racks for displaying rolled merchandise
US4606918A (en) 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4681870A (en) * 1985-01-11 1987-07-21 Imre Corporation Protein A-silica immunoadsorbent and process for its production
JPH0832637B2 (ja) 1985-02-14 1996-03-29 アクゾ・エヌ・ヴエー 合成免疫原
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
ES2052685T3 (es) 1987-03-17 1994-07-16 Akzo Nv Metodo para producir un adyuvante libre.
US5252328A (en) 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
EP0283840A3 (en) 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
ES2097840T3 (es) 1987-11-03 1997-04-16 Syntex Inc Adyuvante de vacuna que comprende un tetrapoliol.
US4985243A (en) 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US5240706A (en) 1989-04-07 1993-08-31 Ml Technology Ventures, L.P. Intranasal administration of Mycoplasma hyopneumoniae antigen
ZA906806B (en) 1989-08-31 1991-06-26 Ici Australia Operations Plants
US6113916A (en) 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
AU657907B2 (en) 1990-05-29 1995-03-30 Wyeth Holdings Corporation Mycoplasma hyopneumoniae vaccine
US5695769A (en) 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
DE69201441T3 (de) 1991-06-06 2008-12-04 Boehringer Ingelheim Vetmedica Gmbh Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
SG43852A1 (en) 1991-08-26 1997-11-14 Boehringer Animal Health Inc Sirs vaccine and diagnosis method
AU2684792A (en) 1991-10-14 1993-05-21 Akzo Nobel N.V. Porcine reproductive respiratory syndrome vaccine and diagnostic
ES2194841T3 (es) 1991-11-15 2003-12-01 Pfizer Procedimiento de produccion de vacunas bacterianas gram negativas.
FR2686097B1 (fr) 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5534256A (en) 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US5695766A (en) 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
US6380376B1 (en) 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6773908B1 (en) 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6592873B1 (en) 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US6251397B1 (en) 1992-10-30 2001-06-26 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same
ES2074950B1 (es) 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
EP1820512B1 (en) 1994-05-10 2013-07-03 Boehringer Ingelheim Vetmedica, Inc. Improved modified live brsv vaccine
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
DE19601754A1 (de) 1996-01-19 1997-07-24 Hoechst Ag Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung
US5846735A (en) 1996-04-18 1998-12-08 University Of Iowa Research Foundation Hepatitis C virus Fc-binding function
GB9622159D0 (en) 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
DE69740108D1 (de) 1996-12-20 2011-03-10 Univ Texas Moraxella catarrhalis antigene uspa1 und uspa2
ID26951A (id) 1997-11-26 2001-02-22 Univ Iowa State Res Found Inc Vaksin mycoplasma hyopneumontae recombinan
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6342231B1 (en) 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
NZ513289A (en) 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US6632439B2 (en) 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6585981B1 (en) 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
JP2005515162A (ja) 2001-07-02 2005-05-26 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）を用いた単回ワクチン接種
MXPA03011924A (es) * 2001-07-02 2004-03-26 Pfizer Prod Inc Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
EP1546357B1 (en) 2002-06-28 2013-08-07 Iowa State University Research Foundation, Inc. Immunogenic mycoplasma hyopneumoniae polypeptides
PL1651265T3 (pl) * 2003-07-24 2008-10-31 Merial Ltd Formulacje szczepionek zawierających emulsję olej w wodzie
CA2587321A1 (en) 2005-01-13 2006-07-20 Boehringer Ingelheim Vetmedica Gmbh Improved prrs vaccines
CN101277717A (zh) * 2005-09-09 2008-10-01 英特威国际有限公司 Pcv-2疫苗
EP1792996A1 (en) 2005-12-01 2007-06-06 Consejo Superior de Investigaciones Cientificas Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV)
CA2635430A1 (en) * 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
RU2408386C2 (ru) * 2006-04-10 2011-01-10 Интервет Интернэшнл Б.В. Вакцина против микоплазмы и prrsv
KR101358517B1 (ko) 2006-04-10 2014-02-06 인터벳 인터내셔널 비.브이. 마이코플라즈마 ｐｒｒｓｖ에 대한 백신
PT2094872T (pt) * 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
US8444989B1 (en) 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
KR101320192B1 (ko) 2008-10-16 2013-10-30 조에티스 엘엘씨 토크 테노 바이러스(ｔｔｖ) 분리물 및 조성물
FI20096134A0 (fi) 2009-11-03 2009-11-03 Pulse Finland Oy Säädettävä antenni
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
EP2609428B1 (en) 2010-08-27 2016-02-10 Intervet International B.V. Potency test for vaccine formulations
UA108902C2 (uk) 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
MX362166B (es) 2012-03-07 2018-12-14 Ceva Sante Animale Nueva vacuna veterinaria.
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028472A1 (en) * 1995-03-16 1996-09-19 The University Of Melbourne Antigen composition against mycoplasma
US7622124B2 (en) * 2000-12-19 2009-11-24 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
WO2004058142A2 (en) * 2002-05-17 2004-07-15 Wyeth Improved combine vaccine against mycoplasma hyopneumoniae and porcine viruses
RU2008130927A (ru) * 2005-12-29 2010-02-10 Берингер Ингельхайм Ветмедика, Инк. (Us) Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций
RU2010117614A (ru) * 2007-11-06 2011-12-20 ВАЙЕТ ЭлЭлСи (US) Авирулентная адъювантная живая вакцина против mycoplasma hyopneumoniae
WO2009126356A2 (en) * 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
WO2011141443A1 (en) * 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Drexler CS. Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets. Veterinary record. 2010 Jan. V.166. No.3. P.:70-74. Chen A.Y. ET AL. Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice. Vaccine. 2008. V. 26. No. 34. P. 4372-;4378. Djordjevic SP. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Australian veterinary journal. 1997. V.75. No.7. P.:504-511. *
Grau-Roma L. ET AL Recent advances in the epidemiology, diagnosis and control of diseases caused by porcinecircovirus type 2. Veterinary journal. 2011. V.187. No.1. P.23-32. Drexler CS. Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets. Veterinary record. 2010 Jan. V.166. No.3. P.:70-74. Chen A.Y. ET AL. Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice. Vaccine. 2008. V. 26. No. 34. P. 4372-;4378. Djordjevic SP. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Australian veterinary journal. 1997. V.75. No.7. P.:504-511. *
Okada M. ET AL. Protective effect of vaccination with culture supernate of M. hyopneumoniae against experimental infection in pigs. Journal of veterinary medicine. 2000. V.47. No 7. P.:527-533. Okada M. ET AL. Cytological and immunological changes in bronchoalveolar lavage fluid and histological observation of lung lesions in pigs immunized with Mycoplasma hyopneumoniae inactivated vaccine prepared from broth culture supernate. Vaccine. 2000. V.18. No. 25. P.:2825-2831. *
Okada M. ET AL. Protective effect of vaccination with culture supernate of M. hyopneumoniae against experimental infection in pigs. Journal of veterinary medicine. 2000. V.47. No 7. P.:527-533. Okada M. ET AL. Cytological and immunological changes in bronchoalveolar lavage fluid and histological observation of lung lesions in pigs immunized with Mycoplasma hyopneumoniae inactivated vaccine prepared from broth culture supernate. Vaccine. 2000. V.18. No. 25. P.:2825-2831. Grau-Roma L. ET AL Recent advances in the epidemiology, diagnosis and control of diseases caused by porcinecircovirus type 2. Veterinary journal. 2011. V.187. No.1. P.23-32. *

Also Published As

Publication number Publication date
HRP20190563T1 (hr) 2019-05-17
US9125885B2 (en) 2015-09-08
US20200338187A1 (en) 2020-10-29
PH12014502251A1 (en) 2014-12-15
KR20180049221A (ko) 2018-05-10
NI201400119A (es) 2015-03-05
ES2721925T3 (es) 2019-08-06
US20190209673A1 (en) 2019-07-11
AU2013243537A1 (en) 2014-10-09
HK1206609A1 (en) 2016-01-15
RS58481B1 (sr) 2019-04-30
MX336503B (es) 2016-01-21
ZA201406974B (en) 2016-07-27
EP2833910B1 (en) 2019-02-13
WO2013152083A3 (en) 2013-12-19
CO7160025A2 (es) 2015-01-15
KR102003620B1 (ko) 2019-07-24
JP2015512449A (ja) 2015-04-27
BR112014024785B1 (pt) 2021-06-08
CL2014002675A1 (es) 2014-12-12
EP2833910A2 (en) 2015-02-11
SI2833910T1 (sl) 2019-05-31
CY1121998T1 (el) 2020-10-14
CN104334186B (zh) 2018-11-13
CN104334186A (zh) 2015-02-04
TWI602574B (zh) 2017-10-21
US20130266602A1 (en) 2013-10-10
UA114503C2 (uk) 2017-06-26
RU2014140106A (ru) 2016-05-27
KR20150003259A (ko) 2015-01-08
PL2833910T3 (pl) 2019-10-31
MY174622A (en) 2020-05-02
CA2869594A1 (en) 2013-10-10
AR090615A1 (es) 2014-11-26
HUE043322T2 (hu) 2019-08-28
MY199179A (en) 2023-10-19
TW201345549A (zh) 2013-11-16
BR112014024785A2 (pt) 2017-07-11
KR20170051528A (ko) 2017-05-11
LT2833910T (lt) 2019-04-25
PT2833910T (pt) 2019-05-23
TR201904603T4 (tr) 2019-04-22
JP6271503B2 (ja) 2018-01-31
CR20140437A (es) 2014-11-10
DK2833910T3 (en) 2019-04-15
MX2014012015A (es) 2014-11-10
HRP20140954A2 (hr) 2015-01-30
US9649369B2 (en) 2017-05-16
MX354759B (es) 2018-03-20
US20150283222A1 (en) 2015-10-08
US10206993B2 (en) 2019-02-19
AU2013243537B2 (en) 2017-10-12
CA2869594C (en) 2018-06-19
PH12014502251B1 (en) 2014-12-15
US20170216423A1 (en) 2017-08-03
US11154609B2 (en) 2021-10-26
US10668145B2 (en) 2020-06-02
EP3508218A1 (en) 2019-07-10
WO2013152083A2 (en) 2013-10-10

Similar Documents

Publication Publication Date Title
US11154609B2 (en) PCV/mycoplasma hyopneumoniae vaccine
US11141472B2 (en) Mycoplasma hyopneumoniae vaccine
RU2644256C2 (ru) Комбинированная вакцина pcv/mycoplasma hyopneumoniae/prrs (pcv/mycoplasma hyopneumoniae/prrs combination vaccine)
CN104271153B (zh) Pcv/猪肺炎支原体/prrs组合疫苗
HK40010885A (en) Pcv/mycoplasma hyopneumoniae combination vaccine
HK1206609B (en) Pcv/mycoplasma hyopneumoniae combination vaccine